Article Abstract

NGM282: A step forward in the nonalcoholic steatohepatitis treatment landscape?

Authors: Luca Valenti, Valerio Nobili


Nonalcoholic fatty liver disease (NAFLD) is becoming the leading cause of liver disease worldwide, and the prevalence is still increasing, especially during the developmental age (1-3). NAFLD is defined in the presence of increased hepatic fat content not explained by at risk alcohol intake, and is epidemiologically associated with obesity, insulin resistance and metabolic disorders.